All In Biotech

Drug Trial Radar · NCT02578602

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

MR Techniques in the Evaluation of Hepatocellular Carcinoma: Gadoxetate

Last checked: Nov 20, 2026Latest source record: Oct 19, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

26

Actual

Start

Oct 2010

Primary completion

Nov 2014

Study completion Jun 2015

Sponsor

Lead sponsor
University of Southern CaliforniaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI)
First posted
Oct 19, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot clinical trial studies magnetic resonance imaging (MRI) with gadoxetate disodium in measuring tumors in patients with liver cancer. Diagnostic procedures, such as MRI with gadoxetate disodium, may help find and diagnose liver cancer and find out how far the disease has spread. It is not yet known whether MRI with gadoxetate disodium provides a more precise measurement of liver tumors than standard computed tomography (CT).

Conditions

  • Adult Hepatocellular Carcinoma
  • Advanced Adult Hepatocellular Carcinoma
  • BCLC Stage 0 Adult Hepatocellular Carcinoma
  • BCLC Stage A Adult Hepatocellular Carcinoma
  • BCLC Stage B Adult Hepatocellular Carcinoma
  • BCLC Stage C Adult Hepatocellular Carcinoma
  • BCLC Stage D Adult Hepatocellular Carcinoma
  • Localized Non-Resectable Adult Liver Carcinoma
  • Localized Resectable Adult Liver Carcinoma

Interventions

  • Gadoxetate DisodiumDrug

    Given IV

  • Magnetic Resonance ImagingDevice

    Undergo MRI with gadoxetate disodium

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Precision in tumor measurement for each type of image (CT vs. MRI), for each phase ( 4 for CT and 5 for MRI), and for each method of measuring "size" (1-,2-, and 3-dimensional), assessed by low inter- and intra-reader variabilityTime frame: Up to 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.